Search Results

The Precision G Blood Glucose Testing System is intended for in vitro diagnostic use (i.e., for external use only) for the quantitative measurement of glucose in fresh whole blood. The Precision G Blood Glucose Testing System is intended for home or professional use. The product may also be used by healthcare professionals for quantitative measurement of glucose in venous or arterial whole blood, provided the sample is used within 15 minutes.

The Precision G Blood Glucose Testing System utilizes amperometric biosensor technology to quantitatively measure glucose in whole blood and control solutions. A drop of whole blood or control solution is applied to the target area of the test strip and the assay is automatically initiated. A countdown begins and glucose oxidase catalyzes the oxidation of glucose to produce gluconic acid. During the reaction, electrons are transferred by an electrochemical mediator to the electrode surface, generating a current that is measured by the Precision G Sensor. The size of the current is proportional to the amount of glucose present in the sample, thus giving an accurate reading of glucose concentration after 20 seconds.

Here's an analysis of the provided text, focusing on acceptance criteria and study information for the Precision G Blood Glucose Testing System:

1. Table of Acceptance Criteria and Reported Device Performance

The provided text does not explicitly state pre-defined acceptance criteria (e.g., "The correlation coefficient must be > 0.95"). Instead, it presents the results of performance studies and then draws a conclusion based on those results. The conclusion acts as a post-hoc assessment of whether the performance is deemed acceptable.

Therefore, the table below presents the reported device performance, and the "Acceptance Criteria" column reflects what was concluded to be acceptable based on the reported values.

Conclusion from the document: "The correlation coefficients and slopes obtained were close to 1.000 and y-intercepts close to 0 mg/dL indicating good correlation of the MediSense Precision G Blood Glucose Testing System to the reference analyzer when testing was conducted by trained operators and lay users. In addition, equivalent results were achieved by Lay Users and Trained Operators using the Precision G Blood Glucose Testing System."

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size for Test Set: N = 200 for each comparison (Lay User vs. YSI, Trained Operator vs. YSI, Trained Operator vs. Lay User).
• Data Provenance: The document does not explicitly state the country of origin. It describes "Accuracy Performance... versus the YSI," implying a controlled laboratory or clinical setting. The term "Accuracy Performance... when used by lay users" suggests that some of the data might have been collected from non-clinical environments, but this is not fully clear. It is a prospective study as it involves the "performance information on clinical accuracy" of the device in comparison to a reference.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

• Number of Experts: Not specified.
• Qualifications of Experts: Not specified. However, the ground truth is established by a "reference analyzer" (YSI), which likely refers to a laboratory-grade glucose analyzer, suggesting that the results from this analyzer are considered the gold standard, not the interpretation of human experts in this context.

4. Adjudication Method for the Test Set

• Adjudication Method: Not applicable. The ground truth is established by a reference analyzer (YSI), which typically provides objective quantitative measurements, not subjective interpretations requiring adjudication.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size of AI Improvement

• MRMC Study: No, this is not an MRMC study. This study assesses the accuracy of a blood glucose testing system against a reference laboratory method (YSI) and compares performance between trained operators and lay users. It does not involve AI assistance for human readers.
• Effect Size of AI Improvement: Not applicable, as there is no AI component or human reader assistance being evaluated in this context.

6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

• Standalone Performance: Yes, the device itself provides a quantitative reading ("quantitatively measure glucose"). Although human operators (trained and lay users) interact with the device to obtain the sample and initiate the test, the "device performance" or "system performance" against the YSI can be considered a standalone assessment of the device's accuracy in producing glucose concentration values. The comparison between trained operator and lay user performance also assesses the robustness of the standalone device, given varying operator proficiency.

7. The Type of Ground Truth Used

• Type of Ground Truth: The ground truth for glucose measurements is established by a reference analyzer, specifically the "YSI." This implies a highly accurate and validated laboratory method for determining blood glucose concentration.

8. The Sample Size for the Training Set

• Sample Size for Training Set: The document does not provide information about a separate training set. The "Performance Studies" described appear to be validation or testing studies only. For a medical device like a blood glucose meter, the "training" usually refers to the internal development and calibration data, which is not typically disclosed in a summary of safety and effectiveness.

9. How the Ground Truth for the Training Set Was Established

• How Ground Truth for Training Set Was Established: Not mentioned in the provided text, as no explicit training set is discussed.

Ask a specific question about this device